FTO and cancer: In addition, some researchers have focused on targeted cancer therapies related to m6A, such as treatment with R-2HG to increase m6A mRNA modification in R-2HG-sensitive leukemia cells by inhibiting FTO activity, thus generating antileukemia effects [151].